Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).
Related Articles
News
Healthy but Sedentary Individuals Show Early Decline in Cellular Energy Production
June 29, 2026
UCBN
News, Syndication
Comments Off on Healthy but Sedentary Individuals Show Early Decline in Cellular Energy Production
Researchers at the University of Colorado Anschutz have found that healthy yet sedentary individuals show a significant, coordinated drop in muscle mitochondrial function that may precede the development of major diseases like cancer, diabetes, and […]
News
Sports-Related Concussions: What Happens to Reaction Times?
November 4, 2025
UCBN
News, Syndication
Comments Off on Sports-Related Concussions: What Happens to Reaction Times?
When playing sports, it’s important to remember: Brains don’t have seat belts. And when rapid acceleration or deceleration of the brain inside the skull occurs with a blow to the head, a concussion happens, which, […]
News
Major healthcare providers to merge Denver operations
July 21, 2026
UCBN
News, Syndication
Comments Off on Major healthcare providers to merge Denver operations
The deal involves eight regional hospitals and dozens of medical practices that will be managed by one system. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech […]
